# Urology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Hubert H. Humphrey (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML022-SYN-TD
- Date: 1977-02-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Elaine Kowalczyk, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Walter Brandvold, MD

## Reason for consultation

Man of 65, three months after radical cystoprostatectomy with an ileal conduit at a cancer center for multifocal urothelial carcinoma with carcinoma in situ, pT2a N0, margins negative. Please share his survivorship surveillance close to home, review his stoma, and set the metabolic monitoring plan. **S**

## History

Mr. Humphrey is seen at the request of Dr. Brandvold four months after radical cystoprostatectomy with an ileal conduit. His bladder history goes back many years: benign growths, then possibly cancerous tissue treated with intravesical thiotepa and pelvic radiation, and then recurrent multifocal tumors with carcinoma in situ in a small irradiated bladder, which led to early cystectomy. He has recovered well and works full time. For three weeks the appliance has leaked about twice a week at night, and the skin below the stoma is sore. He has had no fever, flank pain, or blood in the urine. Erections have not returned since surgery. He is independent in his stoma care. **S**

## Examination

| System | Finding |
|---|---|
| General | Well |
| Abdomen | Soft; healed midline incision; no incisional hernia |
| Stoma | Right lower abdomen; pink and moist; 28 mm, budded about 1.5 cm; moist erythema in a 1 cm band below the stoma without satellite lesions; a skin crease below the stoma when sitting; no parastomal bulge on coughing |
| Lymph nodes | No inguinal nodes |

BP 128/78 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 77.2 kg; BMI 23.8 kg/m². All vital signs are synthetic.

## Data reviewed

Cystoscopy and resection pathology, the operative note and cystectomy pathology (pT2a, 0 of 18 nodes, margins negative), the pre-operative CT of the chest, abdomen, and pelvis with urography, and the first-visit chemistry, blood count, and vitamin B12. PHQ-2: 0. All results are synthetic.

## Assessment

1. **Urothelial carcinoma of the bladder, pT2a pN0, margins negative, after radical cystoprostatectomy** (Z85.51). Organ-confined, node-negative disease. Upstaging from non-muscle-invasive disease at resection to pT2a at cystectomy is common, which is one reason early cystectomy is offered for high-risk disease that recurs after intravesical therapy, especially in an irradiated bladder. Adjuvant cisplatin-based chemotherapy or immunotherapy is offered for pT3 to pT4 or node-positive disease; for pT2a N0 with negative margins, the benefit does not justify the toxicity, and none is recommended. The main risks are recurrence in the pelvis or at distant sites and a new tumor in the upper tracts or the urethra. **S**
2. **Ileal conduit urostomy with appliance leaks and moisture dermatitis** (Z93.6). The leaks come from a skin crease below the stoma when he sits, which a flat wafer cannot seal. The skin change is irritant dermatitis from urine, not candida. The stoma itself is healthy, with good spout height. Later problems to watch for are parastomal hernia, stomal stenosis or retraction, and peristomal skin overgrowth from chronic urine contact. **S**
3. **Kidney and metabolic effects of the ileal conduit** (Z90.6). Reabsorption of chloride and ammonium from urine in the ileal segment causes hyperchloremic metabolic acidosis in some patients; his bicarbonate is at the lower limit. Kidney function can decline from infection, obstruction at the ureteric anastomoses, or reflux. Vitamin B12 deficiency is uncommon with the short segment used for a conduit, but yearly checks are advised from two to three years after surgery. **S**
4. **Urine findings with a conduit**. Conduit urine is almost always colonized, and the dipstick and culture from the bag are usually abnormal. Bacteriuria without symptoms should not be treated. Fever, flank pain, rigors, or a rise in creatinine suggest upper-tract infection, which needs a culture taken by sterile catheter through the stoma and prompt treatment. **S**
5. **Retained urethra**. The urethral margin was negative and the prostatic urethra was not involved, so the risk of urethral recurrence is low and routine urethral wash cytology is not needed; bloody discharge from the urethra should be reported. **S**

## Recommendations

1. No adjuvant chemotherapy or immunotherapy.
2. CT of the chest, abdomen, and pelvis with a urographic phase at one year after surgery, then every 6 to 12 months to three years, then yearly; urology review with each scan.
3. Renal ultrasound at six months after surgery for hydronephrosis, then upper-tract imaging with each CT.
4. Chemistry with creatinine, chloride, and bicarbonate every 3 to 6 months in the first year, then yearly; start sodium bicarbonate 650 mg twice daily if bicarbonate falls below 22 mmol/L, or earlier for symptoms; vitamin B12 yearly from two to three years after surgery.
5. Stoma: convex wafer with a barrier ring, changed every three to four days, stoma powder and barrier film until the skin heals, and a night drainage bag; fitted today by the wound, ostomy, and continence nurse.
6. Do not culture or treat conduit urine without symptoms. For fever or flank pain, culture by catheter through the stoma and treat as a complicated urinary tract infection; check creatinine, and image the kidneys if fever persists beyond 48 to 72 hours.
7. About 2 liters of fluid a day; report blood from the stoma, flank pain, or a bulge around the stoma.
8. Erectile dysfunction after cystoprostatectomy: options (a PDE5 inhibitor, a vacuum device, or penile injections) explained; he does not want treatment now.

## Strengths and supports

- Supports: family, close friends, and a large circle of colleagues **S**

## Communication

Discussed with Dr. Brandvold today. The patient agrees with the plan and has the stoma nurse's direct number. **S**

## Follow-up

Stoma nurse by telephone in one week. Urology review with the one-year CT, sooner for any problem. Primary care arranges the chemistry, the six-month ultrasound, and the yearly B12, and manages infections and acid-base. **S**

## Guideline basis

- Holzbeierlein J, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024). J Urol 2024;212(1):3-10 (2024), American Urological Association, American Society of Clinical Oncology, and Society of Urologic Oncology
- Holzbeierlein JM, et al. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment. J Urol 2024;211(4):533-538 (2024), American Urological Association and Society of Urologic Oncology
- NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer (2026), National Comprehensive Cancer Network
- CMID: Clinical Monitoring Intelligence Database, urologic cancer monograph (2026), Aether Forge
